Results for “ ”

Entry Author Date Location
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire 06/16/20 San Francisco
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug 06/15/20 National
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear 06/15/20 Boston
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Early Bird Sale Ends Friday, June 5 for Xconomy’s AI & Drug Discovery Online Forum and Networking Conference 06/04/20 National
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Grail Plants a Seed in RTP, Pledges $100M Investment in New Site 06/02/20 Raleigh Durham
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech 06/02/20 Seattle
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut 05/20/20 San Francisco
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs 05/20/20 San Francisco
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study 05/11/20 National
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021 05/11/20 San Francisco
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Page 2 of 202 « previous page · next page »